Ibogaine Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature
This can be blocked by the serotonin 5-HT2A receptor antagonist ketanserin, by the mTOR inhibitor rapamycin, and by a TrkB antagonist. Induction of gamma oscillations… Read More »Ibogaine Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature
